Vitros® 4600

Ortho VITROS® Chemistry, Immunoassay, and Integrated Systems are designed to boost laboratory efficiency by reducing errors and eliminating the need for repeat testing. These advanced systems operate without water, cutting down on both costs and waste, while delivering a remarkable 96.5% first pass yield—ensuring reliable results on the first try. With VITROS® XT Solutions, labs enjoy up to 25% faster turnaround times for common test panels, and the new XT analyzers deliver up to 40% higher throughput for increased productivity. The systems use very low sample volumes (2–80 µL) and offer a comprehensive test menu that includes critical assays such as SARS‑CoV‑2 IgG, HIV combo, procalcitonin, immunosuppressive drugs, and drugs of abuse. This integration of clinical chemistry and immunoassay testing simplifies workflows, reduces operating costs, and improves turnaround times so your lab can focus on patient care.

Key Points:

• Waterless Operation: Eliminates water use, lowering costs and waste disposal.
• High First Pass Yield: Delivers 96.5% first pass yield, reducing repeat tests.
• Rapid Turnaround: XT Solutions offer up to 25% faster turnaround times for common panels.
• High Throughput: New XT analyzers achieve up to 40% higher throughput.
• Low Sample Volume: Requires only 2–80 µL per test.
• Comprehensive Assay Menu: Supports a wide range of tests, including SARS‑CoV‑2, HIV, procalcitonin, and more.